Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 198

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease

Buckley, Rachel F., Maruff, Paul, Ames, David, Bourgeat, Pierrick, Martins, Ralph N., Masters, Colin L., Rainey‐Smith, Stephanie, Lautenschlager, Nicola, Rowe, Christopher C., Savage, Greg, Villemagne, Victor L., Ellis, Kathryn A., AIBL study·2016·Alzheimer's & Dementia

Abstract

Introduction: The objective of this study was to determine the utility of subjective memory decline (SMD) to predict episodic memory change and rates of clinical progression in cognitively normal older adults with evidence of high β‐amyloid burden (CN Aβ+). Methods: Fifty‐eight CN Aβ+ participants from the Australian Imaging, Biomarkers, and Lifestyle study responded to an SMD questionnaire and underwent comprehensive neuropsychological assessments. Participant data for three follow‐up assessments were analyzed. Results: In CN Aβ+, subjects with high SMD did not exhibit significantly greater episodic memory decline than those with low SMD. High SMD was related to greater rates of progression to mild cognitive impairment or Alzheimer's disease (AD) dementia (hazard ratio = 5.1; 95% confidence interval, 1.4–20.0, P = .02) compared with low SMD. High SMD was associated with greater depressive symptomatology and smaller left hippocampal volume. Discussion: High SMD is a harbinger of greater rates of clinical progression in preclinical AD. Although SMD reflects broader diagnostic implications for CN Aβ+, more sensitive measures may be required to detect early subtle cognitive change.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2015.12.013

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 198

Metadata

Authors
Buckley, R. F., Maruff, P., Ames, D., Bourgeat, P., Martins, R. N., Masters, C. L., Rainey‐Smith, S., Lautenschlager, N., Rowe, C. C., Savage, G., Villemagne, V. L., Ellis, K. A., & study, A.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2016-02-04
Volume
12
Issue
7
Pages
796-804
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2261904358
Cited by
198
References
17
FWCI
13.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2015.12.013
The paper
Buckley, R. F., Maruff, P., Ames, D., Bourgeat, P., Martins, R. N., Masters, C. L., Rainey‐Smith, S., Lautenschlager, N., Rowe, C. C., Savage, G., Villemagne, V. L., Ellis, K. A., & study, A. (2016). Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2015.12.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.